Mesenchymal Stem Cells (MSCs) are the engines behind regeneration. Numerous clinical studies worldwide focus on the regenerative potential of stem cell therapy using MSCs. Initially, most stem cell therapies in the U.S. were provided by using a person’s own cells extracted from bone marrow or fat. But mounting evidence has demonstrated the superior therapeutic potentials of birth tissue-derived stem cells. This lecture presents scientific evidence of such. Presented by Joy Kong, M.D., triple board-certified, UCLA-trained physician, the president of the American Academy of Integrative Cell Therapy.
